Shanghai Fosun Pharmaceutical Group Co Ltd (600196 SHG) stock market data APIs

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. manufactures, distributes, and sells pharmaceutical products in Mainland China and internationally. The company offers pharmaceutical products for oncology and immunomodulation, metabolism and digestive system, anti-infection, central nervous system, and cardiovascular system; and APIs and intermediates, including amino acid, tranexamic acid, levamisole hydrochloride, and clindamycin hydrochloride. It also provides mRNA vaccines for Covid-19; medical devices for medical cosmetologym personal care, dentistry, injection filling, respiratory health, mobile pre-hospital care, professional in-hospital surgery, and surgical robots and medical consumables for pre-hospital emergency, neurosurgery, orthopedics, and oncology fields; and solutions for biochemical, immune, molecular, microbiological, and pathological diagnosis, as well as chronic care management. In addition, the company offers online and offline medical services, such as pharmaceuticals and medical devices, consumer healthcare and healthcare commodities, and other comprehensive commodities; specialized medical treatment; and insurance services. The company was founded in 1994 and is based in Shanghai, China.